N-acetylglucosamine Conjugated to Nanoparticles Enhances Myocyte Uptake and Improves Delivery of a Small Molecule p38 Inhibitor for Post-infarct Healing

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Cardiovascular Translational Research

• Publication date

  2011-08-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12265-011-9292-0PMID 21833815PMCID PMC3176982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery.

  2010cited by this paper
• Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces.

  2010influential reference
• The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

  2010cited by this paper
• Apoptosis predominates in nonmyocytes in heart failure.

  2009cited by this paper
• Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study

  2009cited by this paper
• Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.

  2008cited by this paper
• Cardioprotection by N-Acetylglucosamine Linkage to Cellular Proteins

  2008cited by this paper
• Cardiomyocyte death and renewal in the normal and diseased heart.

  2008cited by this paper
• Targeted delivery of catalase and superoxide dismutase to macrophages using folate.

  2007cited by this paper
• Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro.

  2007influential reference
• Overexpression of BAR attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice

  2007cited by this paper
• Surface biofunctionalization of PLA nanoparticles through amphiphilic polysaccharide coating and ligand coupling: Evaluation of biofunctionalization and drug releasing behavior

  2007cited by this paper
• Polyketal microparticles: a new delivery vehicle for superoxide dismutase.

  2007cited by this paper
• Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers.

  2005cited by this paper
• Apoptosis and heart failure: clinical relevance and therapeutic target.

  2005cited by this paper
• Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP

  2005cited by this paper
• Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.

  2005cited by this paper
• Antioxidant enzyme gene expression in congestive heart failure following mycardial infarction

  2003cited by this paper
• Effect of pegylation on pharmaceuticals

  2003cited by this paper
• Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury.

  2003cited by this paper
• Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.

  2003cited by this paper
• Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo

  2001cited by this paper
• Cytoprotection by Jun Kinase During Nitric Oxide–Induced Cardiac Myocyte Apoptosis

  2001cited by this paper
• Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.

  2001cited by this paper
• Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure.

  2000cited by this paper
• Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

  2000influential reference
• Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2.

  1999cited by this paper
• MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes.

  1999cited by this paper
• Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family*

  1998cited by this paper
• Myocyte proliferation in end-stage cardiac failure in humans.

  1998cited by this paper
• Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice.

  1998cited by this paper
• Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis.

  1998cited by this paper
• Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

  1997cited by this paper
• Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53.

  1997cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper
• Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

  1997cited by this paper
• Desmin Is Essential for the Tensile Strength and Integrity of Myofibrils but Not for Myogenic Commitment, Differentiation, and Fusion of Skeletal Muscle

  1997cited by this paper
• Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney*

  1997cited by this paper
• Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion.

  1996cited by this paper
• Cell cycle control mechanisms and their role in cardiac growth.

  1995cited by this paper
• Preparation and characterization of liposomes as therapeutic delivery systems: a review.

  1995cited by this paper
• The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion.

  1994cited by this paper
• Bcl-2 functions in an antioxidant pathway to prevent apoptosis.

  1993cited by this paper
• Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase

  1984cited by this paper
• Desmin and vimentin coexist at the periphery of the myofibril Z disc.

  1979cited by this paper
• Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration.

  1977cited by this paper

• Microbial production of N-acetyl-D-glucosamine (GlcNAc) for versatile applications: Biotechnological strategies for green process development.

  2024cites this paper
• The Role of Antioxidants in the Therapy of Cardiovascular Diseases—A Literature Review

  2024cites this paper
• Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects

  2022cites this paper
• Oxidative stress - Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders.

  2022cites this paper
• Recent advances in degradable synthetic polymers for biomedical applications – Beyond polyesters

  2022cites this paper
• Synthesis, Characterization, In Silico Analysis, and Pharmacological Evaluation of Metoprolol-Modified Saccharide Conjugates for Cardiovascular Targeting

  2021cites this paper
• A REVIEW ON BASICS AND APPLICATIONS OF MODIFIED CARBOHYDRATES IN DRUG DELIVERY

  2021cites this paper
• Engineering Carbohydrate-Based Particles for Biomedical Applications: Strategies to Construct and Modify.

  2021cites this paper
• Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure.

  2021cites this paper
• Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation

  2021cites this paper
• Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries

  2021cites this paper
• Nanostructured Polymeric, Liposomal and Other Materials to Control the Drug Delivery for Cardiovascular Diseases

  2020cites this paper
• Identification and characterization of small molecule modulators of cardiac hypertrophy

  2020cites this paper
• Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases

  2020cites this paper
• Synthesis and characterization of novel 99mTc-DGC nano-complexes for improvement of heart diagnostic.

  2020cites this paper
• Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

  2019cites this paper
• Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine

  2018cites this paper
• Theranostic nanoparticles for the management of inflammatory diseases and conditions

  2017cites this paper
• High-throughput screening identifies microRNAs that target Nox 2 and improve function 1 following acute myocardial infarction 2 3

  2017cites this paper
• Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases

  2017cites this paper
• High-throughput screening identifies microRNAs that target Nox2 and improve function following acute myocardial infarction

  2017cites this paper
• Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology

  2017cites this paper
• Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.

  2016cites this paper
• Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes

  2016cites this paper
• Modulation of the immune response following myocardial infarction utilizing biomaterial-based therapeutic delivery strategies

  2015cites this paper
• Micro- and Nanoparticles for Treating Cardiovascular Disease.

  2015cites this paper
• Nanomedicines for Endothelial Disorders.

  2015cites this paper
• Dysregulation of Catalase Activity in Newborn Myocytes During Hypoxia Is Mediated by c-Abl Tyrosine Kinase

  2015cites this paper
• Heart regeneration after myocardial infarction using synthetic biomaterials.

  2015cites this paper
• Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.

  2015cites this paper
• Engineering stem cell responses using oxidative stress and notch ligand containing hydrogels

  2014cites this paper
• Chapter 13 – Polyacetals

  2014cites this paper
• Ceria nanoparticles stabilized by organic surface coatings activate the lysosome-autophagy system and enhance autophagic clearance.

  2014cites this paper
• p38 MAPK in cardioprotection – are we there yet?

  2014cites this paper
• Development of therapeutic systems to treat the infarcted heart

  2014cites this paper
• Micro- and Nanofabrication Approaches to Cardiac Tissue Engineering

  2014cites this paper
• Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticle-mediated delivery of mature microRNAs.

  2013cites this paper
• Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction.

  2013cites this paper
• Synthesis and polymerization of bicyclic ketals: a practical route to high-molecular weight polyketals.

  2013cites this paper
• Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair.

  2013cites this paper
• Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.

  2013cites this paper
• Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

  2013cites this paper
• Basic Science for Clinicians New Therapeutic Targets in Cardiology p38 Alpha Mitogen-Activated Protein Kinase for Ischemic Heart Disease

  2012cites this paper
• New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease.

  2012cites this paper
• p38 Alpha Mitogen-Activated Protein Kinase for Ischemic Heart Disease

  2012cites this paper
• The impact of nanotechnology on myocardial infarction treatment.

  2012cites this paper